10-Q Filing

ACCELERATE DIAGNOSTICS, INC CIK: 727207 Q2 2012

Filing Information

Form Type	10-Q
Accession Number	`0001000096-12-000054`
Period End Date	20120131
Filing Date	20120315
Fiscal Year	2012
Fiscal Period	Q2
XBRL Instance	axk-20120131.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 56 Income Statement 76 Cash Flow Statement 48

Balance Sheet 56 line items

Line Item	Tag	Value	Unit	Period
Common Stock, no par value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common Stock, no par value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	19.00M	shares	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	19.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$775.86K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$513.03K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$283.27K	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	10.76M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$425.27K	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	10.76M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	10.76M	shares	Point-in-time
Trade Accounts receivable	`ReceivablesNetCurrent`	$595.91K	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	10.76M	shares	Point-in-time
Trade Accounts receivable	`ReceivablesNetCurrent`	$596.13K	USD	Point-in-time
Shares held for employee benefit	`DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital`	$1.13M	USD	Point-in-time
Inventory	`InventoryNet`	$30.28K	USD	Point-in-time
Inventory	`InventoryNet`	$30.28K	USD	Point-in-time
Shares held for employee benefit	`DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital`	$1.13M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$41.07K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$20.58K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.18M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.42M	USD	Point-in-time
Long Term Accounts Receivable, Net of current portion	`LongTermInvestmentsAndReceivablesNet`	$745.44K	USD	Point-in-time
Long Term Accounts Receivable, Net of current portion	`LongTermInvestmentsAndReceivablesNet`	$745.44K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$3.53K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.50K	USD	Point-in-time
Investments, net	`Goodwill`	$1.39M	USD	Point-in-time
Investments, net	`Goodwill`	$1.30M	USD	Point-in-time
Intellectual property, net	`FiniteLivedIntangibleAssetsNet`	$2.69M	USD	Point-in-time
Intellectual property, net	`FiniteLivedIntangibleAssetsNet`	$2.79M	USD	Point-in-time
Total assets	`Assets`	$6.26M	USD	Point-in-time
Total assets	`Assets`	$6.01M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$101.33K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$34.96K	USD	Point-in-time
Accrued compensation and other liabilities	`EmployeeRelatedLiabilitiesCurrent`	$24.58K	USD	Point-in-time
Accrued compensation and other liabilities	`EmployeeRelatedLiabilitiesCurrent`	$32.76K	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$9.80K	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$96.95K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$69.34K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$231.04K	USD	Point-in-time
Deferred compensation	`DeferredCompensationLiabilityCurrent`	$1.43M	USD	Point-in-time
Deferred compensation	`DeferredCompensationLiabilityCurrent`	$1.38M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.66M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.45M	USD	Point-in-time
Common Stock, no par value; 19,000,000 shares authorized; 10,757,317 shares issued and outstanding	`CommonStockNoParValue`	$14.33M	USD	Point-in-time
Common Stock, no par value; 19,000,000 shares authorized; 10,757,317 shares issued and outstanding	`CommonStockNoParValue`	$14.33M	USD	Point-in-time
Contributed capital	`AdditionalPaidInCapitalCommonStock`	$1.25M	USD	Point-in-time
Contributed capital	`AdditionalPaidInCapitalCommonStock`	$1.54M	USD	Point-in-time
Accumulated (deficit)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-11.24M	USD	Point-in-time
Accumulated (deficit)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-10.49M	USD	Point-in-time
Shares held for employee benefit (1,129,110 shares at cost)	`SharesHeldInEmployeeStockOptionPlanAllocated`	-273,600.00	shares	Point-in-time
Shares held for employee benefit (1,129,110 shares at cost)	`SharesHeldInEmployeeStockOptionPlanAllocated`	-273,600.00	shares	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$4.35M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$4.82M	USD	Point-in-time
Total liabilities and shareholders' equity	`LiabilitiesAndStockholdersEquity`	$6.01M	USD	Point-in-time
Total liabilities and shareholders' equity	`LiabilitiesAndStockholdersEquity`	$6.26M	USD	Point-in-time

Income Statement 76 line items

Line Item	Tag	Value	Unit	Period
OptiChem(R) revenues	`LicensesRevenue`	$15.04K	USD	2 Qtrs
OptiChem(R) revenues	`LicensesRevenue`	$20.34K	USD	2 Qtrs
OptiChem(R) revenues	`LicensesRevenue`	$8.33K	USD	1 Quarter
OptiChem(R) revenues	`LicensesRevenue`	$3.16K	USD	1 Quarter
Technical development fees	`ProfessionalAndContractServicesExpense`	-	USD	1 Quarter
Technical development fees	`ProfessionalAndContractServicesExpense`	$-520.41K	USD	2 Qtrs
Technical development fees	`ProfessionalAndContractServicesExpense`	$-310.41K	USD	1 Quarter
Technical development fees	`ProfessionalAndContractServicesExpense`	$-140.00K	USD	2 Qtrs
Product Licensing Fees	`CostOfServicesLicensesAndServices`	-	USD	1 Quarter
Product Licensing Fees	`CostOfServicesLicensesAndServices`	-	USD	2 Qtrs
Product Licensing Fees	`CostOfServicesLicensesAndServices`	$-50.00K	USD	2 Qtrs
Product Licensing Fees	`CostOfServicesLicensesAndServices`	-	USD	1 Quarter
Qualified Therapeutic Discovery Grant	`RevenueFromGrants`	-	USD	1 Quarter
Qualified Therapeutic Discovery Grant	`RevenueFromGrants`	-	USD	2 Qtrs
Qualified Therapeutic Discovery Grant	`RevenueFromGrants`	-	USD	1 Quarter
Qualified Therapeutic Discovery Grant	`RevenueFromGrants`	$244.48K	USD	2 Qtrs
Total Revenues	`SalesRevenueNet`	$779.93K	USD	2 Qtrs
Total Revenues	`SalesRevenueNet`	$8.33K	USD	1 Quarter
Total Revenues	`SalesRevenueNet`	$210.34K	USD	2 Qtrs
Total Revenues	`SalesRevenueNet`	$313.57K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$193.04K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$107.11K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$88.88K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$218.16K	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$425.34K	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$657.25K	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$189.77K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$198.26K	USD	1 Quarter
Amortization	`AmortizationOfIntangibleAssets`	$63.22K	USD	1 Quarter
Amortization	`AmortizationOfIntangibleAssets`	$126.40K	USD	2 Qtrs
Amortization	`AmortizationOfIntangibleAssets`	$64.26K	USD	1 Quarter
Amortization	`AmortizationOfIntangibleAssets`	$128.35K	USD	2 Qtrs
Marketing and sales	`SellingAndMarketingExpense`	$46.00	USD	1 Quarter
Marketing and sales	`SellingAndMarketingExpense`	$6.49K	USD	2 Qtrs
Marketing and sales	`SellingAndMarketingExpense`	$4.22K	USD	2 Qtrs
Marketing and sales	`SellingAndMarketingExpense`	$500.00	USD	1 Quarter
Depreciation	`DepreciationDepletionAndAmortization`	$515.00	USD	1 Quarter
Depreciation	`DepreciationDepletionAndAmortization`	$599.00	USD	1 Quarter
Depreciation	`DepreciationDepletionAndAmortization`	$1.03K	USD	2 Qtrs
Depreciation	`DepreciationDepletionAndAmortization`	$1.20K	USD	2 Qtrs
Total costs and expenses	`CostsAndExpenses`	$361.20K	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$351.96K	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$983.88K	USD	2 Qtrs
Total costs and expenses	`CostsAndExpenses`	$777.59K	USD	2 Qtrs
Income (Loss) from operations	`OperatingIncomeLoss`	$-773.54K	USD	2 Qtrs
Income (Loss) from operations	`OperatingIncomeLoss`	$-343.63K	USD	1 Quarter
Income (Loss) from operations	`OperatingIncomeLoss`	$2.34K	USD	2 Qtrs
Income (Loss) from operations	`OperatingIncomeLoss`	$-47.63K	USD	1 Quarter
Interest and dividend income	`OtherNonoperatingIncome`	$7.84K	USD	2 Qtrs
Interest and dividend income	`OtherNonoperatingIncome`	$7.40K	USD	2 Qtrs
Interest and dividend income	`OtherNonoperatingIncome`	$3.83K	USD	1 Quarter
Interest and dividend income	`OtherNonoperatingIncome`	$3.96K	USD	1 Quarter
Unrealized gain (loss) on investments	`UnrealizedGainLossOnInvestments`	$15.61K	USD	1 Quarter
Unrealized gain (loss) on investments	`UnrealizedGainLossOnInvestments`	$31.14K	USD	2 Qtrs
Unrealized gain (loss) on investments	`UnrealizedGainLossOnInvestments`	$11.24K	USD	2 Qtrs
Unrealized gain (loss) on investments	`UnrealizedGainLossOnInvestments`	$17.31K	USD	1 Quarter
Gain on sale of equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$1.00K	USD	2 Qtrs
Gain on sale of equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	2 Qtrs
Gain on sale of equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	1 Quarter
Gain on sale of equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$1.00K	USD	1 Quarter
Total other income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$20.08K	USD	2 Qtrs
Total other income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$21.27K	USD	1 Quarter
Total other income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$20.45K	USD	1 Quarter
Total other income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$38.55K	USD	2 Qtrs
Net Income (loss)	`NetIncomeLoss`	$-753.46K	USD	2 Qtrs
Net Income (loss)	`NetIncomeLoss`	$-323.19K	USD	1 Quarter
Net Income (loss)	`NetIncomeLoss`	$-26.36K	USD	1 Quarter
Net Income (loss)	`NetIncomeLoss`	$40.89K	USD	2 Qtrs
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	$-0.07	USD	2 Qtrs
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	$-0.03	USD	1 Quarter
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	-	USD	2 Qtrs
Weighted average shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	10.76M	shares	1 Quarter
Weighted average shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	11.10M	shares	2 Qtrs
Weighted average shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	11.10M	shares	1 Quarter
Weighted average shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	10.76M	shares	2 Qtrs

Cash Flow Statement 48 line items

Line Item	Tag	Value	Unit	Period
Net Income (loss)	`NetIncomeLoss`	$-753.46K	USD	2 Qtrs
Net Income (loss)	`NetIncomeLoss`	$-323.19K	USD	1 Quarter
Net Income (loss)	`NetIncomeLoss`	$-26.36K	USD	1 Quarter
Net Income (loss)	`NetIncomeLoss`	$40.89K	USD	2 Qtrs
Depreciation	`Depreciation`	$1.03K	USD	2 Qtrs
Depreciation	`Depreciation`	$1.20K	USD	2 Qtrs
Amortization	`AmortizationOfIntangibleAssets`	$63.22K	USD	1 Quarter
Amortization	`AmortizationOfIntangibleAssets`	$126.40K	USD	2 Qtrs
Amortization	`AmortizationOfIntangibleAssets`	$64.26K	USD	1 Quarter
Amortization	`AmortizationOfIntangibleAssets`	$128.35K	USD	2 Qtrs
Fair value of stock options granted for services	`ShareBasedCompensation`	$12.13K	USD	2 Qtrs
Fair value of stock options granted for services	`ShareBasedCompensation`	$288.36K	USD	2 Qtrs
Unrealized holding (gain) loss on investments	`GainLossOnInvestments`	$-11.24K	USD	2 Qtrs
Unrealized holding (gain) loss on investments	`GainLossOnInvestments`	$-31.14K	USD	2 Qtrs
Reinvested earnings-interest and dividends	`OtherNoncashExpense`	$-2.84K	USD	2 Qtrs
Reinvested earnings-interest and dividends	`OtherNoncashExpense`	$-3.70K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-5.30K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$213.00	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	-	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$-300.00	USD	2 Qtrs
Prepaid expense and other	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-20.49K	USD	2 Qtrs
Prepaid expense and other	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-18.05K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$43.54K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$66.38K	USD	2 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$8.18K	USD	2 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$3.90K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-4.08K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$87.15K	USD	2 Qtrs
Deferred compensation	`DeferredCompensationArrangementWithIndividualCompensationExpense`	$52.45K	USD	2 Qtrs
Deferred compensation	`DeferredCompensationArrangementWithIndividualCompensationExpense`	$71.49K	USD	2 Qtrs
Net cash provided (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$237.83K	USD	2 Qtrs
Net cash provided (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-156.80K	USD	2 Qtrs
Purchases of equipment and patents	`PaymentsToAcquirePropertyPlantAndEquipment`	$-20.84K	USD	2 Qtrs
Purchases of equipment and patents	`PaymentsToAcquirePropertyPlantAndEquipment`	$-31.03K	USD	2 Qtrs
Contribution to deferred compensation trust	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition`	$-75.00K	USD	2 Qtrs
Contribution to deferred compensation trust	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition`	$-75.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-95.83K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-106.03K	USD	2 Qtrs
Increase (Decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-262.83K	USD	2 Qtrs
Increase (Decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$141.99K	USD	2 Qtrs
Beginning balance	`CashAndCashEquivalentsAtCarryingValue`	$775.86K	USD	Point-in-time
Beginning balance	`CashAndCashEquivalentsAtCarryingValue`	$513.03K	USD	Point-in-time
Beginning balance	`CashAndCashEquivalentsAtCarryingValue`	$283.27K	USD	Point-in-time
Beginning balance	`CashAndCashEquivalentsAtCarryingValue`	$425.27K	USD	Point-in-time
Ending balance	`CashAndCashEquivalentsAtCarryingValue`	$775.86K	USD	Point-in-time
Ending balance	`CashAndCashEquivalentsAtCarryingValue`	$513.03K	USD	Point-in-time
Ending balance	`CashAndCashEquivalentsAtCarryingValue`	$283.27K	USD	Point-in-time
Ending balance	`CashAndCashEquivalentsAtCarryingValue`	$425.27K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.